InvestorsHub Logo

snayeman

07/11/20 10:13 AM

#310135 RE: Blue Fin #310127

It’s not nit picking to ask questions in a quest to get better educated on an event that has occurred, not all are doing this I know but some are! And I’m trying to figure out what truly these filings represent

MinnieM

07/11/20 10:16 AM

#310136 RE: Blue Fin #310127

More research on Brilacidin coming out soon in print.
Future Microbiol 2020 Jul 10. doi: 10.2217/fmb-2020-0048. Online ahead of print.

https://pubmed.ncbi.nlm.nih.gov/32648783/

Tackling Antimicrobial Resistance by Exploring New Mechanisms of Antibiotic Action
Cruz L Matos de Opitz 1, Peter Sass 1 2

Affiliations
1 Department of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology & Infection Medicine, University of Tübingen, Auf der Morgenstelle 28, 72076 Tübingen, Germany.

2 German Center for Infection Research (DZIF), Partner Site Tübingen, Germany.

Keywords: ADEP; afabicin; brilacidin; cyclomarin A; drug discovery; murepavadin; ribocil; ridinilazole; teixobactin; ß-lactones.